PTN

Palatin Tech

11.59

+1.26+12.20%

After Hours: 12.00 +0.41 +3.54%17:50 07/02 EDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE10.88/10.33

TODAY RANGE10.11-11.71

VOL25.55K

MARKET CAP20.62M

52 WEEK RANGE5.00-31.00

AVG VOL (3M)17.41K

% TURNOVER1.44%

TURNOVER--

P/E (TTM)-6.8495

% RANGE15.49%

EPS(TTM)-1.6921

P/E(FORWARD)-4.5451

P/B1.944

BVPS5.96

DIVIDEND--

P/S1.238

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP18.28M

SHARES OUTSTANDING1.78M

NEXT EARNINGS09/21-09/25

FREE FLOAT1.58M

LOT SIZE1

EX-DATE08/12/2025

News

Press Releases

Financial Reports

Profile

TipRanks·06/17 18:30
Palatin Technologies Is Pursuing the Next Generation of MC4R. Rhythm Just Reinforced Why That Matters
TipRanks·05/18 22:51
Palatin Technologies Voluntarily Transfers Stock Listing to Nasdaq
TipRanks·05/18 20:08
Palatin announces approval of its common stock by Nasdaq
PR Newswire·05/18 20:00
Palatin to Begin Trading on Nasdaq Stock Exchange
TipRanks·05/14 17:24
Palatin price target lowered to $47.50 from $50 at Alliance Global
TipRanks·05/14 00:46
Palatin Technologies Earnings Call: Partnerships, Progress, Risks
Benzinga·05/13 15:31
Transcript: Palatin Techs Q3 2026 Earnings Conference Call
TipRanks·05/13 12:30
Palatin Is Betting on the Next Generation of Obesity Drugs (NYSE: PTN)
Benzinga·05/13 11:37
Palatin Techs Q3 EPS $(0.37) Beats $(1.26) Estimate, Sales $3.921M Beat $1.283M Estimate
Seeking Alpha·05/13 11:34
Palatin Technologies GAAP EPS of -$0.37, revenue of $3.9M
Dow Jones·05/13 11:32
*Palatin Technologies: Runway To Fund Operations Through June 2027 >PTN
Dow Jones·05/13 11:32
*Palatin Technologies 3Q Rev $3.92M >PTN
Dow Jones·05/13 11:30
*Palatin Technologies 3Q Loss/Shr 37c >PTN
Dow Jones·05/13 11:30
Press Release: Palatin Reports Fiscal Third Quarter 2026 Financial Results and Provides Business Update
Dow Jones·05/13 11:30
Press Release: Palatin Reports Fiscal Third -2-

Same Industry

Name/Symbol

Change%

Price

PTN

Regeneron Pharmaceuticals

REGN

+4.73%

654.27

GridAI Tech

GRDX

+1.85%

4.410

BNTX

United Therapeutics Corp.

UTHR

+0.42%

544.92

Vertex Pharmaceuticals Inc

VRTX

+6.03%

528.04

Siga Technologie

SIGA

+3.76%

3.860

Moderna

MRNA

-0.54%

69.33

Charles Riv Labs Intl Inc

CRL

+0.70%

230.69

Medpace Holdings

MEDP

+1.37%

527.07

Talphera Inc

TLPH

-3.74%

1.030

ICON plc

ICLR

-1.14%

173.06

China Biologic

CBPO

0.00%

119.99

Iqvia Hldgs Inc

IQV

+2.53%

191.14

MOLECULAR PARTNERS AG

MOLN

+1.55%

3.930

Arcturus Therape

ARCT

+0.88%

6.88

Gilead Sciences Inc

GILD

-1.21%

126.33

PRA Health

PRAH

0.00%

165.21

INCY

Aptevo Therapeutics Inc

APVO

+0.23%

4.450

Biospecifics

BSTC

+0.15%

88.53

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.